Ethnic disparities in waitlist outcomes of patients with nonalcoholic steatohepatitis listed for liver transplantation in the US.
Journal
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
ISSN: 1527-6473
Titre abrégé: Liver Transpl
Pays: United States
ID NLM: 100909185
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
received:
07
12
2022
accepted:
06
03
2023
medline:
23
10
2023
pubmed:
12
4
2023
entrez:
11
4
2023
Statut:
ppublish
Résumé
NASH is the fastest-growing cause of liver cirrhosis and is the leading indication for liver transplantation (LT). However, significant racial and ethnic disparities in waitlist outcomes and LT allocation may unfairly disadvantage minorities. Our aim was to characterize racial and ethnic disparities in waitlist mortality and transplantation probability among patients with NASH. This is a retrospective analysis of the United Network for Organ Sharing registry data of LT candidates from January 1, 2000 to December 31, 2021. Outcomes analysis was performed using competing risk analysis with the Fine and Gray model. The multivariable adjustment was conducted, and mixed-effect regression was used to compare the model for end-stage liver disease scores at listing and removal. Of 18,562 patients with NASH cirrhosis, there were 14,834 non-Hispanic Whites, 349 African Americans, 2798 Hispanics, 312 Asians, and 269 of other races/ethnicities; African American (effect size: 2.307, 95% CI: 1.561-3.053, and p < 0.001) and Hispanic (effect size: 0.332, 95% CI: 0.028-0.637, p = 0.032) patients were found to have a significantly higher model for end-stage liver disease scores at the time of listing than non-Hispanic Whites. African Americans had a higher probability of receiving LT relative to non-Hispanic Whites (subdistribution HR: 1.211, 95% CI: 1.051-1.396, and p = 0.008). However, Hispanic race/ethnicity was associated with a lower transplantation probability (subdistribution HR: 0.793, 95% CI: 0.747-0.842, and p < 0.001) and increased waitlist mortality (subdistribution HR: 1.173, CI: 1.052-1.308, and p = 0.004) compared with non-Hispanic Whites. There are significant racial and ethnic disparities in waitlist outcomes of patients with NASH in the US. Hispanic patients are less likely to receive LT and more likely to die while on the waitlist compared with non-Hispanic Whites despite being listed with a lower model for end-stage liver disease scores.
Identifiants
pubmed: 37039547
doi: 10.1097/LVT.0000000000000148
pii: 01445473-990000000-00143
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1181-1191Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2023 American Association for the Study of Liver Diseases.
Références
Younossi ZM, Stepanova M, Ong J, Trimble G, AlQahtani S, Younossi I, et al. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States. Clin Gastroenterol Hepatol. 2021;19:580–9 e585.
Tan PS, Muthiah MD, Koh T, Teoh YL, Chan A, Kow A, et al. Asian liver transplant network clinical guidelines on immunosuppression in liver transplantation. Transplantation. 2019;103:480.
Tang A, Ng CH, Phang PH, Chan KE, Chin YH, Fu CE, et al. Comparative burden of metabolic dysfunction in lean NAFLD vs non-lean NAFLD—a systematic review and meta-analysis. Clinical Gastroenterol Hepatol. 2022;19:S1542–3565 (22)00669-3.
Truong E, Yeo YH, Cook‐Wiens G, Muthiah M, Yang JD, Sundaram V, et al. Nonalcoholic fatty liver disease prevalence and severity in Asian Americans from the national health and nutrition examination surveys 2017-2018. Hepatol Commun. 2022;6:2253–61.
Yong JN, Lim WH, Ng CH, Tan DJH, Xiao J, Tay PWL, et al. Outcomes of nonalcoholic steatohepatitis after liver transplantation: an updated meta-analysis and systematic review. Clin Gastroenterol Hepatol. 2021;18:18.
Godfrey EL, Malik TH, Lai JC, Mindikoglu AL, Galván NTN, Cotton RT, et al. The decreasing predictive power of MELD in an era of changing etiology of liver disease. Am J Transplant. 2019;19:3299–307.
Laderian B, Murali AR, Sanchez AJ. Outcomes of patients with nonalcoholic steatohepatitis with cirrhosis and low model for end stage liver disease score. Am J Gastroenterol. 2019;114:S581–2.
Kemmer N. Ethnic disparities in liver transplantation. Gastroenterol Hepatol (N Y). 2011;7:302–7.
Nicole E, Rich SO, Mufti AR, Browning JD, Parikh ND, Odewole M, et al. Racial and ethnic disparities in nonalcoholic fatty liver disease prevalence, severity, and outcomes in the United States: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16:198–210.e2.
Carrion AF, Ghanta R, Carrasquillo O, Martin P. Chronic liver disease in the Hispanic population of the United States. Clin Gastroenterol Hepatol. 2011;9:834–41.
Kim D, Li AA, Perumpail BJ, Gadiparthi C, Kim W, Cholankeril G, et al. Changing trends in etiology-based and ethnicity-based annual mortality rates of cirrhosis and hepatocellular carcinoma in the United States. Hepatology. 2019;69:1064–74.
Eckhoff DE, McGuire BM, Young CJ, Sellers MT, Frenette LR, Hudson SL, et al. Race: a critical factor in organ donation, patient referral and selection, and orthotopic liver transplantation?. Liver Transpl Surg. 1998;4:499–505.
Julapalli VR, Kramer JR, El-Serag HB. Evaluation for liver transplantation: adherence to AASLD referral guidelines in a large Veterans Affairs center. Liver Transpl. 2005;11:1370–8.
Moylan CA, Brady CW, Johnson JL, Smith AD, Tuttle-Newhall JE, Muir AJ. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371–8.
Kemmer N, Zacharias V, Kaiser TE, Neff GW. Access to liver transplantation in the MELD era: role of ethnicity and insurance. Dig Dis Sci. 2009;54:1794–7.
Henson JB, Wilder JM, Kappus MR, Barbas AS, Moylan CA, Niedzwiecki D, et al. Transplant outcomes in older patients with nonalcoholic steatohepatitis compared to alcohol-related liver disease and hepatitis C. Transplantation. 2020;104:e173.
Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148:547–55.
Cholankeril G, Wong RJ, Hu M, Perumpail RB, Yoo ER, Puri P, et al. Liver transplantation for nonalcoholic steatohepatitis in the US: temporal trends and outcomes. Dig Dis Sci. 2017;62:2915–22.
Caldwell SH, Lee VD, Kleiner DE, Al-Osaimi AMS, Argo CK, Northup PG, et al. NASH and cryptogenic cirrhosis: a histological analysis. Ann Hepatol. 2009;8:346–52.
Contos MJ, Cales W, Sterling RK, Luketic VA, Shiffman ML, Mills AS, et al. Development of nonalcoholic fatty liver disease after orthotopic liver transplantation for cryptogenic cirrhosis. Liver Transpl. 2001;7:363–73.
Yalamanchili K, Saadeh S, Klintmalm GB, Jennings LW, Davis GL. Nonalcoholic fatty liver disease after liver transplantation for cryptogenic cirrhosis or nonalcoholic fatty liver disease. Liver Transpl. 2010;16:431–9.
Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Racial and ethnic disparities in access to liver transplantation. Liver Transpl. 2010;16:1033–40.
OPTN. Notice of OPTN Policy and Guidance Changes: Improving Liver Allocation: MELD, PELD, Status 1A, Status 1B. Accessed November 2, 2022. https://optntransplanthrsagov/media/3idbp5vq/policy-guid-change_impr-liv-alloc-meld-peld-sta-1a-sta-1b_livpdf
Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing Risk. J Am Stat Assoc. 1999;94:496–509.
Diez-Roux AV. Multilevel analysis in public health research. Annu Rev Public Health. 2000;21:171–92.
Goldstein H, Browne W, Rasbash J. Multilevel modelling of medical data. Stat Med. 2002;21:3291–315.
Day, Jennifer Cheeseman, Population Projections of the United States by Age, Sex, Race, and Hispanic Origin: 1995 to 2050, U.S. Bureau of the Census, Current Population Reports, P25- 1130, U.S. Government Printing Office, Washington, DC, 1996.
Mathur AK, Sonnenday CJ, Merion RM Race and Ethnicity in Access to and Outcomes of Liver Transplantation: a Critical Literature Review. 2009;9:2662–2668
Shemesh E, Kleinman LC, Howell EA, Annunziato R. Racial and economic disparities in transplant outcomes: the not-so-hidden morbidities. Liver Transpl. 2014;20:4–6
Volk ML, C 1H, Warren GJW, Sonnenday CJ, Marrero JA, Heisler M. Geographic variation in organ availability is responsible for disparities in liver transplantation between Hispanics and Caucasians. Am J Transplant. 2009;9:2113–2118.
Hsu C, Yang W, Parikh RV, Anderson AH, Chen TK, Cohen DL, et al. for the CRIC Study Investigators. Race, genetic ancestry, and estimating kidney function in CKD. N Engl J Med. 2021;385:1750–1760.
Bernards S, Lee E, Leung N, Akan M, Gan K, Zhao H, et al. Awarding additional MELD points to the shortest waitlist candidates improves sex disparity in access to liver transplant in the United States. Am J Transplant. 2022;22:2912–2920.
Fryar CD, Kruszon-Moran D, Gu Q, Ogden CL. Mean Body Weight, Height, Waist Circumference, and Body Mass Index Among Adults: United States, 1999–2000 through 2015–2016. Natl Health Stat Repor. 2018:1–16.
Mathur AK, Schaubel DE, Gong Q, Guidinger MK, Merion RM. Racial and ethnic disparities in access to liver transplantation. Liver Transpl. 2010;16:1033–40.